Long-Term Effects Secondary to Cancer Therapy in Adults Unknown Status Phase 3 Trials for Cyproterone acetate (DB04839)

IndicationStatusPhase
DBCOND0038922 (Long-Term Effects Secondary to Cancer Therapy in Adults)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00632983Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate CancerTreatment